Insurance: formulary, prior authorization, step therapy, copay, deductible and pharmacy benefit
The study isnt yet peer-reviewed, but it appears to show retatrutide leaving other GLP-1s in the dust: The highest dose made patients lose an average of 28% of their body mass after 80 weeks, running nearly a full lap around the highest dose of Novo Nordisks Wegovy (~15% weight loss after 68 weeks)
Tirzepatide drops and other novel delivery methods each carry their own timing rules
Updated: 11 hours ago | A local food critic is recovering after a three-week battle with cyclosporiasis, a parasite found in produce that has been spreading across the country
Zhou X, Huang G, Wang L, Zhao Y, Li J, Chen D, et al
February 2024: In February 2024, the United States Judicial Panel on Multidistrict Litigation (MDL Panel), agreed to consolidate lawsuits involving glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including Trulicity